Pulsed field ablation could soon be used in the majority of electrophysiology procedures to treat atrial fibrillation as ...

Citi raised the firm’s price target on Boston Scientific (BSX) to $107 from $98 and keeps a Buy rating on the shares. The firm also added the ...

Four PFA systems have launched in the U.S. in the past year: Medtronic’s PulseSelect and Affera Sphere-9, Boston Scientific’s Farapulse and J&J's Varipulse. The Citi survey polled 36 ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Boston Scientific (BSX – Research Report), with a ...

Valued at a market cap of $133.6 billion, Boston Scientific Corporation (BSX ... strategic acquisitions like Farapulse, its category leadership strategy, and robust operational execution ...

Boston Scientific Corporation BSX remains in the spotlight, with its stock currently trading close to its 52-week high. In the past six trading sessions, the stock has consistently traded above $90.00 ...

Valued at a market cap of $133.6 billion, Boston Scientific Corporation (BSX) develops, manufactures, and markets medical ...

presents significant growth opportunities for Boston Scientific's Watchman device. 1. Product Pipeline: The successful launch of new products, such as the U.S. Farapulse PFA, is expected to ...

Dr. Robert Ward prepares part of the FARAPULSE Pulsed Field Ablation System for a pulsed field ablation procedure to treat a patient with atrial fibrillation at Mayo Clinic Hospital, Saint Marys ...

2 The FARAPULSE system (Boston Scientific), comprising a single-shot, pentaspline, multielectrode catheter (FARAWAVE) and a pulsed-field energy generator, was the first PFA system to become ...

AFib-treating cardiac ablation, surgical robotics, nitinol and diabetes treatment tech lead among this year’s top medtech ...